Cargando…
DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer
Although most prostate cancer (PCa) cases are not life-threatening, approximately 293 000 men worldwide die annually due to PCa. These lethal cases are thought to be caused by coordinated genomic alterations that accumulate over time. Recent genome-wide analyses of DNA from subjects with PCa have re...
Autor principal: | Liu, Wennuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955176/ https://www.ncbi.nlm.nih.gov/pubmed/26975494 http://dx.doi.org/10.4103/1008-682X.177120 |
Ejemplares similares
-
Translation of genomics and epigenomics in prostate cancer: progress and promising directions
por: Liu, Wennuan, et al.
Publicado: (2016) -
Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019) -
Genomic predictors for treatment of late stage prostate cancer
por: Shevrin, Daniel H
Publicado: (2016) -
Clinically available RNA profiling tests of prostate tumors: utility and comparison
por: Na, Rong, et al.
Publicado: (2016) -
Clinical variability and molecular heterogeneity in prostate cancer
por: Shoag, Jonathan, et al.
Publicado: (2016)